HEADER DNA BINDING PROTEIN 27-SEP-21 7PTF TITLE PSEUDOMONAS AERUGINOSA DNA GYRASE B 24KDA ATPASE SUBDOMAIN COMPLEXED TITLE 2 WITH NOVOBIOCIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA GYRASE SUBUNIT B; COMPND 3 CHAIN: A, B, C; COMPND 4 EC: 5.6.2.2; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: CORRESPONDS TO RESIDUES 1-221 OF FULL-LENGTH WILD-TYPE COMPND 7 PROTEIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA (STRAIN ATCC 15692 / DSM SOURCE 3 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1); SOURCE 4 ORGANISM_TAXID: 208964; SOURCE 5 STRAIN: ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 SOURCE 6 / 1C / PRS 101 / PAO1; SOURCE 7 GENE: GYRB, PA0004; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS DNA GYRASE, GYRB, INHIBITOR, ANTIBACTERIAL, ISOMERASE, DNA BINDING KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.E.COTMAN,A.ZEGA,N.ZIDAR,J.ILAS,T.TOMASIC,L.P.MASIC,J.E.A.MUNDY, AUTHOR 2 C.E.M.STEVENSON,N.BURTON,D.M.LAWSON,A.MAXWELL,D.KIKELJ REVDAT 3 07-FEB-24 7PTF 1 REMARK REVDAT 2 19-APR-23 7PTF 1 JRNL REVDAT 1 05-OCT-22 7PTF 0 JRNL AUTH A.E.COTMAN,M.DURCIK,D.BENEDETTO TIZ,F.FULGHERI,D.SECCI, JRNL AUTH 2 M.STERLE,S.MOZINA,Z.SKOK,N.ZIDAR,A.ZEGA,J.ILAS, JRNL AUTH 3 L.PETERLIN MASIC,T.TOMASIC,D.HUGHES,D.L.HUSEBY,S.CAO, JRNL AUTH 4 L.GAROFF,T.BERRUGA FERNANDEZ,P.GIACHOU,L.CRONE,I.SIMOFF, JRNL AUTH 5 R.SVENSSON,B.BIRNIR,S.V.KOROL,Z.JIN,F.VICENTE,M.C.RAMOS, JRNL AUTH 6 M.DE LA CRUZ,B.GLINGHAMMAR,L.LENHAMMAR,S.R.HENDERSON, JRNL AUTH 7 J.E.A.MUNDY,A.MAXWELL,C.E.M.STEVENSON,D.M.LAWSON, JRNL AUTH 8 G.V.JANSSEN,G.J.STERK,D.KIKELJ JRNL TITL DISCOVERY AND HIT-TO-LEAD OPTIMIZATION OF BENZOTHIAZOLE JRNL TITL 2 SCAFFOLD-BASED DNA GYRASE INHIBITORS WITH POTENT ACTIVITY JRNL TITL 3 AGAINST ACINETOBACTER BAUMANNII AND PSEUDOMONAS AERUGINOSA. JRNL REF J.MED.CHEM. V. 66 1380 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 36634346 JRNL DOI 10.1021/ACS.JMEDCHEM.2C01597 REMARK 2 REMARK 2 RESOLUTION. 1.32 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.32 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 109.11 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 143035 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.150 REMARK 3 R VALUE (WORKING SET) : 0.148 REMARK 3 FREE R VALUE : 0.177 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 7512 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.32 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.35 REMARK 3 REFLECTION IN BIN (WORKING SET) : 10554 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.75 REMARK 3 BIN R VALUE (WORKING SET) : 0.2890 REMARK 3 BIN FREE R VALUE SET COUNT : 550 REMARK 3 BIN FREE R VALUE : 0.3020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4882 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 160 REMARK 3 SOLVENT ATOMS : 642 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.34000 REMARK 3 B22 (A**2) : 0.41000 REMARK 3 B33 (A**2) : -0.67000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.14000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.052 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.049 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.038 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.143 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.977 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.970 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5498 ; 0.008 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 5044 ; 0.001 ; 0.015 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7508 ; 1.313 ; 1.639 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11622 ; 1.424 ; 1.583 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 694 ; 5.945 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 306 ;30.833 ;21.176 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 899 ;11.261 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 45 ;16.831 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 693 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6422 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1277 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 10542 ; 1.139 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 3 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 10 219 B 10 219 6894 0.120 0.050 REMARK 3 2 A 17 220 C 17 220 6647 0.130 0.050 REMARK 3 3 B 17 219 C 17 219 6619 0.120 0.050 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7PTF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-SEP-21. REMARK 100 THE DEPOSITION ID IS D_1292118340. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-FEB-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9126 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 150584 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.320 REMARK 200 RESOLUTION RANGE LOW (A) : 109.110 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.32 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 1.24900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4XTJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 23.69550 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLU A 3 REMARK 465 ASN A 4 REMARK 465 ASN A 5 REMARK 465 THR A 6 REMARK 465 TYR A 7 REMARK 465 ASP A 8 REMARK 465 SER A 9 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLU B 3 REMARK 465 ASN B 4 REMARK 465 ASN B 5 REMARK 465 THR B 6 REMARK 465 TYR B 7 REMARK 465 ASP B 8 REMARK 465 GLY B 221 REMARK 465 MET C 1 REMARK 465 SER C 2 REMARK 465 GLU C 3 REMARK 465 ASN C 4 REMARK 465 ASN C 5 REMARK 465 THR C 6 REMARK 465 TYR C 7 REMARK 465 ASP C 8 REMARK 465 SER C 9 REMARK 465 SER C 10 REMARK 465 SER C 11 REMARK 465 ILE C 12 REMARK 465 LYS C 13 REMARK 465 VAL C 14 REMARK 465 LEU C 15 REMARK 465 LYS C 16 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 86 CG CD CE NZ REMARK 470 LYS B 86 CD CE NZ REMARK 470 LYS B 105 CG CD CE NZ REMARK 470 LYS B 112 CD CE NZ REMARK 470 LYS C 23 CG CD CE NZ REMARK 470 ARG C 24 CG CD NE CZ NH1 NH2 REMARK 470 ASN C 109 CG OD1 ND2 REMARK 470 GLU C 176 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 101 50.24 39.95 REMARK 500 HIS A 101 50.24 39.75 REMARK 500 HIS C 101 69.58 -114.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 612 DISTANCE = 6.06 ANGSTROMS REMARK 525 HOH B 613 DISTANCE = 6.33 ANGSTROMS DBREF 7PTF A 1 221 UNP Q9I7C2 GYRB_PSEAE 1 221 DBREF 7PTF B 1 221 UNP Q9I7C2 GYRB_PSEAE 1 221 DBREF 7PTF C 1 221 UNP Q9I7C2 GYRB_PSEAE 1 221 SEQRES 1 A 221 MET SER GLU ASN ASN THR TYR ASP SER SER SER ILE LYS SEQRES 2 A 221 VAL LEU LYS GLY LEU ASP ALA VAL ARG LYS ARG PRO GLY SEQRES 3 A 221 MET TYR ILE GLY ASP THR ASP ASP GLY THR GLY LEU HIS SEQRES 4 A 221 HIS MET VAL PHE GLU VAL VAL ASP ASN SER ILE ASP GLU SEQRES 5 A 221 ALA LEU ALA GLY TYR CYS SER GLU ILE SER ILE THR ILE SEQRES 6 A 221 HIS THR ASP GLU SER ILE THR VAL ARG ASP ASN GLY ARG SEQRES 7 A 221 GLY ILE PRO VAL ASP ILE HIS LYS GLU GLU GLY VAL SER SEQRES 8 A 221 ALA ALA GLU VAL ILE MET THR VAL LEU HIS ALA GLY GLY SEQRES 9 A 221 LYS PHE ASP ASP ASN THR TYR LYS VAL SER GLY GLY LEU SEQRES 10 A 221 HIS GLY VAL GLY VAL SER VAL VAL ASN ALA LEU SER HIS SEQRES 11 A 221 GLU LEU ARG LEU THR ILE ARG ARG HIS ASN LYS VAL TRP SEQRES 12 A 221 GLU GLN VAL TYR HIS HIS GLY VAL PRO GLN PHE PRO LEU SEQRES 13 A 221 ARG GLU VAL GLY GLU THR ASP GLY SER GLY THR GLU VAL SEQRES 14 A 221 HIS PHE LYS PRO SER PRO GLU THR PHE SER ASN ILE HIS SEQRES 15 A 221 PHE SER TRP ASP ILE LEU ALA LYS ARG ILE ARG GLU LEU SEQRES 16 A 221 SER PHE LEU ASN SER GLY VAL GLY ILE LEU LEU ARG ASP SEQRES 17 A 221 GLU ARG THR GLY LYS GLU GLU LEU PHE LYS TYR GLU GLY SEQRES 1 B 221 MET SER GLU ASN ASN THR TYR ASP SER SER SER ILE LYS SEQRES 2 B 221 VAL LEU LYS GLY LEU ASP ALA VAL ARG LYS ARG PRO GLY SEQRES 3 B 221 MET TYR ILE GLY ASP THR ASP ASP GLY THR GLY LEU HIS SEQRES 4 B 221 HIS MET VAL PHE GLU VAL VAL ASP ASN SER ILE ASP GLU SEQRES 5 B 221 ALA LEU ALA GLY TYR CYS SER GLU ILE SER ILE THR ILE SEQRES 6 B 221 HIS THR ASP GLU SER ILE THR VAL ARG ASP ASN GLY ARG SEQRES 7 B 221 GLY ILE PRO VAL ASP ILE HIS LYS GLU GLU GLY VAL SER SEQRES 8 B 221 ALA ALA GLU VAL ILE MET THR VAL LEU HIS ALA GLY GLY SEQRES 9 B 221 LYS PHE ASP ASP ASN THR TYR LYS VAL SER GLY GLY LEU SEQRES 10 B 221 HIS GLY VAL GLY VAL SER VAL VAL ASN ALA LEU SER HIS SEQRES 11 B 221 GLU LEU ARG LEU THR ILE ARG ARG HIS ASN LYS VAL TRP SEQRES 12 B 221 GLU GLN VAL TYR HIS HIS GLY VAL PRO GLN PHE PRO LEU SEQRES 13 B 221 ARG GLU VAL GLY GLU THR ASP GLY SER GLY THR GLU VAL SEQRES 14 B 221 HIS PHE LYS PRO SER PRO GLU THR PHE SER ASN ILE HIS SEQRES 15 B 221 PHE SER TRP ASP ILE LEU ALA LYS ARG ILE ARG GLU LEU SEQRES 16 B 221 SER PHE LEU ASN SER GLY VAL GLY ILE LEU LEU ARG ASP SEQRES 17 B 221 GLU ARG THR GLY LYS GLU GLU LEU PHE LYS TYR GLU GLY SEQRES 1 C 221 MET SER GLU ASN ASN THR TYR ASP SER SER SER ILE LYS SEQRES 2 C 221 VAL LEU LYS GLY LEU ASP ALA VAL ARG LYS ARG PRO GLY SEQRES 3 C 221 MET TYR ILE GLY ASP THR ASP ASP GLY THR GLY LEU HIS SEQRES 4 C 221 HIS MET VAL PHE GLU VAL VAL ASP ASN SER ILE ASP GLU SEQRES 5 C 221 ALA LEU ALA GLY TYR CYS SER GLU ILE SER ILE THR ILE SEQRES 6 C 221 HIS THR ASP GLU SER ILE THR VAL ARG ASP ASN GLY ARG SEQRES 7 C 221 GLY ILE PRO VAL ASP ILE HIS LYS GLU GLU GLY VAL SER SEQRES 8 C 221 ALA ALA GLU VAL ILE MET THR VAL LEU HIS ALA GLY GLY SEQRES 9 C 221 LYS PHE ASP ASP ASN THR TYR LYS VAL SER GLY GLY LEU SEQRES 10 C 221 HIS GLY VAL GLY VAL SER VAL VAL ASN ALA LEU SER HIS SEQRES 11 C 221 GLU LEU ARG LEU THR ILE ARG ARG HIS ASN LYS VAL TRP SEQRES 12 C 221 GLU GLN VAL TYR HIS HIS GLY VAL PRO GLN PHE PRO LEU SEQRES 13 C 221 ARG GLU VAL GLY GLU THR ASP GLY SER GLY THR GLU VAL SEQRES 14 C 221 HIS PHE LYS PRO SER PRO GLU THR PHE SER ASN ILE HIS SEQRES 15 C 221 PHE SER TRP ASP ILE LEU ALA LYS ARG ILE ARG GLU LEU SEQRES 16 C 221 SER PHE LEU ASN SER GLY VAL GLY ILE LEU LEU ARG ASP SEQRES 17 C 221 GLU ARG THR GLY LYS GLU GLU LEU PHE LYS TYR GLU GLY HET NOV A 301 44 HET MRD A 302 8 HET NOV B 301 44 HET MES B 302 12 HET MRD B 303 8 HET NOV C 301 44 HETNAM NOV NOVOBIOCIN HETNAM MRD (4R)-2-METHYLPENTANE-2,4-DIOL HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETSYN NOV 4-HYDROXY-3-[4-HYDROXY-3-(3-METHYLBUT-2-ENYL) HETSYN 2 NOV BENZAMIDO]-8-METHYLCOUMARIN-7-YL 3-O-CARBAMOYL-5,5-DI- HETSYN 3 NOV C-METHYL-ALPHA-L-LYXOFURANOSIDE FORMUL 4 NOV 3(C31 H36 N2 O11) FORMUL 5 MRD 2(C6 H14 O2) FORMUL 7 MES C6 H13 N O4 S FORMUL 10 HOH *642(H2 O) HELIX 1 AA1 SER A 10 ARG A 24 1 15 HELIX 2 AA2 PRO A 25 GLY A 30 1 6 HELIX 3 AA3 GLY A 35 ALA A 55 1 21 HELIX 4 AA4 SER A 91 VAL A 99 1 9 HELIX 5 AA5 THR A 110 GLY A 115 1 6 HELIX 6 AA6 GLY A 115 GLY A 121 1 7 HELIX 7 AA7 VAL A 122 LEU A 128 1 7 HELIX 8 AA8 SER A 184 ASN A 199 1 16 HELIX 9 AA9 SER B 10 ARG B 24 1 15 HELIX 10 AB1 PRO B 25 GLY B 30 1 6 HELIX 11 AB2 GLY B 35 ALA B 55 1 21 HELIX 12 AB3 ALA B 92 VAL B 99 1 8 HELIX 13 AB4 LYS B 105 THR B 110 5 6 HELIX 14 AB5 GLY B 121 LEU B 128 1 8 HELIX 15 AB6 SER B 184 ASN B 199 1 16 HELIX 16 AB7 LEU C 18 ARG C 24 1 7 HELIX 17 AB8 PRO C 25 GLY C 30 1 6 HELIX 18 AB9 GLY C 35 ALA C 55 1 21 HELIX 19 AC1 ALA C 92 VAL C 99 1 8 HELIX 20 AC2 HIS C 101 PHE C 106 5 6 HELIX 21 AC3 ASP C 107 SER C 114 1 8 HELIX 22 AC4 GLY C 115 HIS C 118 5 4 HELIX 23 AC5 GLY C 121 LEU C 128 1 8 HELIX 24 AC6 SER C 184 ASN C 199 1 16 SHEET 1 AA1 3 VAL A 151 PRO A 152 0 SHEET 2 AA1 3 LYS A 141 HIS A 148 -1 N HIS A 148 O VAL A 151 SHEET 3 AA1 3 ARG A 157 GLU A 161 -1 O VAL A 159 N VAL A 142 SHEET 1 AA2 8 VAL A 151 PRO A 152 0 SHEET 2 AA2 8 LYS A 141 HIS A 148 -1 N HIS A 148 O VAL A 151 SHEET 3 AA2 8 SER A 129 ARG A 138 -1 N LEU A 134 O GLN A 145 SHEET 4 AA2 8 GLY A 166 PRO A 173 -1 O HIS A 170 N ARG A 133 SHEET 5 AA2 8 ILE A 71 ASP A 75 -1 N VAL A 73 O VAL A 169 SHEET 6 AA2 8 GLU A 60 ILE A 65 -1 N SER A 62 O ARG A 74 SHEET 7 AA2 8 GLY A 203 ASP A 208 1 O LEU A 205 N ILE A 63 SHEET 8 AA2 8 GLU A 214 PHE A 217 -1 O PHE A 217 N ILE A 204 SHEET 1 AA3 3 VAL B 151 PRO B 152 0 SHEET 2 AA3 3 LYS B 141 HIS B 148 -1 N HIS B 148 O VAL B 151 SHEET 3 AA3 3 ARG B 157 GLU B 161 -1 O VAL B 159 N VAL B 142 SHEET 1 AA4 8 VAL B 151 PRO B 152 0 SHEET 2 AA4 8 LYS B 141 HIS B 148 -1 N HIS B 148 O VAL B 151 SHEET 3 AA4 8 SER B 129 ARG B 138 -1 N LEU B 134 O GLN B 145 SHEET 4 AA4 8 GLY B 166 PRO B 173 -1 O HIS B 170 N ARG B 133 SHEET 5 AA4 8 ILE B 71 ASP B 75 -1 N VAL B 73 O VAL B 169 SHEET 6 AA4 8 GLU B 60 ILE B 65 -1 N SER B 62 O ARG B 74 SHEET 7 AA4 8 GLY B 203 ASP B 208 1 O LEU B 205 N ILE B 63 SHEET 8 AA4 8 GLU B 214 PHE B 217 -1 O PHE B 217 N ILE B 204 SHEET 1 AA5 2 ILE B 84 HIS B 85 0 SHEET 2 AA5 2 VAL B 90 SER B 91 -1 O VAL B 90 N HIS B 85 SHEET 1 AA6 3 VAL C 151 PRO C 152 0 SHEET 2 AA6 3 LYS C 141 HIS C 148 -1 N HIS C 148 O VAL C 151 SHEET 3 AA6 3 ARG C 157 GLU C 161 -1 O VAL C 159 N VAL C 142 SHEET 1 AA7 8 VAL C 151 PRO C 152 0 SHEET 2 AA7 8 LYS C 141 HIS C 148 -1 N HIS C 148 O VAL C 151 SHEET 3 AA7 8 SER C 129 ARG C 138 -1 N LEU C 134 O GLN C 145 SHEET 4 AA7 8 GLY C 166 PRO C 173 -1 O GLY C 166 N ARG C 137 SHEET 5 AA7 8 ILE C 71 ASP C 75 -1 N VAL C 73 O VAL C 169 SHEET 6 AA7 8 GLU C 60 ILE C 65 -1 N SER C 62 O ARG C 74 SHEET 7 AA7 8 GLY C 203 ASP C 208 1 O LEU C 205 N ILE C 63 SHEET 8 AA7 8 GLU C 214 LYS C 218 -1 O PHE C 217 N ILE C 204 SHEET 1 AA8 2 ILE C 84 HIS C 85 0 SHEET 2 AA8 2 VAL C 90 SER C 91 -1 O VAL C 90 N HIS C 85 CRYST1 62.657 47.391 110.626 90.00 99.49 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015960 0.000000 0.002669 0.00000 SCALE2 0.000000 0.021101 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009165 0.00000